Free Trial
CVE:ACST

Acasti Pharma (ACST) Stock Price, News & Analysis

Acasti Pharma logo
C$0.58 +0.01 (+1.75%)
As of 03/27/2023

About Acasti Pharma Stock (CVE:ACST)

Key Stats

Today's Range
C$0.56
C$0.58
50-Day Range
C$0.58
C$0.58
52-Week Range
C$0.47
C$1.66
Volume
2,450 shs
Average Volume
6,576 shs
Market Capitalization
C$18.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Remove Ads
Receive ACST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter.

ACST Stock News Headlines

It’s Time to Buy Elon’s “ChatGPT Killer”
Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”... “The future of AI”... And “a revolutionary leap forward.” Tech legend and angel investor Jeff Brown believes this AI is so powerful that it will kill ChatGPT… And make a lot of people rich in the process.
ACST Stock Earnings: Acasti Pharma Beats EPS for Q1 2025
Acasti Pharma Inc. (ACST)
Acasti Pharma Inc. Class A
See More Headlines

ACST Stock Analysis - Frequently Asked Questions

Acasti Pharma's stock was trading at C$0.58 on January 1st, 2025. Since then, ACST shares have increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2025 here
.

Shares of ACST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acasti Pharma investors own include Genius Brands International (GNUS), Tesla (TSLA), Workhorse Group (WKHS), Nikola (NKLA), SCYNEXIS (SCYX) and

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:ACST
Previous Symbol
CVE:APO
CIK
N/A
Fax
N/A
Employees
32
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-10,537,760.56
Net Margins
-388.46%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$2.71 million
Cash Flow
C$0.93 per share
Price / Cash Flow
0.63
Book Value
C$0.86 per share
Price / Book
0.67

Miscellaneous

Free Float
N/A
Market Cap
C$18.19 million
Optionable
Not Optionable
Beta
1.22
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (CVE:ACST) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners